Discuss Goldman Sachs Group Inc.
Goldman Sachs Group Inc.
WKN: 920332 / Symbol: GS / Name: Goldman Sachs / Aktie / Investment Banking & Finanzdienstleistungen / Large Cap /
444,70 €
2,77 %
Buy Goldman Sachs Group Inc.
Buy Goldman Sachs Group Inc.
The Goldman Sachs Group, Inc. (NYSE: GS) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $463.00 to $440.00. They now have an "outperform" rating on the stock.
Ratings data for GS provided by MarketBeat
The Goldman Sachs Group, Inc. (NYSE: GS) had its price target lowered by analysts at Wells Fargo & Company from $420.00 to $390.00. They now have an "overweight" rating on the stock.
Ratings data for GS provided by MarketBeat
The Goldman Sachs Group, Inc. (NYSE: GS) had its "outperform" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $410.00 price target on the stock.
Ratings data for GS provided by MarketBeat
The Goldman Sachs Group, Inc. (NYSE: GS) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.
Ratings data for GS provided by MarketBeat
The Goldman Sachs Group, Inc. (NYSE: GS) had its price target raised by analysts at Evercore ISI from $360.00 to $370.00. They now have an "outperform" rating on the stock.
Ratings data for GS provided by MarketBeat
The Goldman Sachs Group, Inc. (NYSE: GS) had its price target lowered by analysts at BMO Capital Markets from $429.00 to $414.00. They now have an "outperform" rating on the stock.
Ratings data for GS provided by MarketBeat
The Goldman Sachs Group, Inc. (NYSE: GS) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $440.00 to $437.00. They now have an "outperform" rating on the stock.
Ratings data for GS provided by MarketBeat
The Goldman Sachs Group, Inc. (NYSE: GS) had its price target raised by analysts at Keefe, Bruyette & Woods from $390.00 to $400.00. They now have an "outperform" rating on the stock.
Ratings data for GS provided by MarketBeat
The Goldman Sachs Group, Inc. (NYSE: GS) was upgraded by analysts at Odeon Capital Group LLC from a "hold" rating to a "buy" rating.
Ratings data for GS provided by MarketBeat
The Goldman Sachs Group, Inc. (NYSE: GS) had its "outperform" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $410.00 price target on the stock.
Ratings data for GS provided by MarketBeat
The Goldman Sachs Group, Inc. (NYSE: GS) had its price target raised by analysts at BMO Capital Markets from $407.00 to $411.00. They now have an "outperform" rating on the stock.
Ratings data for GS provided by MarketBeat
The Goldman Sachs Group, Inc. (NYSE: GS) had its price target raised by analysts at UBS Group AG from $385.00 to $400.00. They now have a "buy" rating on the stock.
Ratings data for GS provided by MarketBeat
The Goldman Sachs Group, Inc. (NYSE: GS) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $483.00 to $461.00. They now have an "outperform" rating on the stock.
Ratings data for GS provided by MarketBeat
The Goldman Sachs Group, Inc. (NYSE: GS) is now covered by analysts at HSBC Holdings plc. They set a "buy" rating and a $403.00 price target on the stock.
Ratings data for GS provided by MarketBeat
The Goldman Sachs Group, Inc. (NYSE: GS) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $461.00 to $450.00. They now have an "outperform" rating on the stock.
Ratings data for GS provided by MarketBeat
The Goldman Sachs Group, Inc. (NYSE: GS) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $450.00 to $447.00. They now have an "outperform" rating on the stock.
Ratings data for GS provided by MarketBeat
The Goldman Sachs Group, Inc. (NYSE: GS) had its price target raised by analysts at Oppenheimer Holdings Inc. from $447.00 to $468.00. They now have an "outperform" rating on the stock.
Ratings data for GS provided by MarketBeat
Buy with target price 370.0
Neueste Beiträge
Cantor_Fitzgerald in Arrowhead Pharmaceuticals Inc. diskutieren